Jiangsu Kanion Pharmaceutical (600557.SH): The domestic first generic drug simvastatin and ezetimibe sodium tablets have been included in the national medical insurance list.

Kangyuan Pharmaceutical (600557.SH) announced that on December 7, 2025, the National Medical Insurance Administration and the Ministry of Human Resources and Social Security issued the "Notice on the Issuance of the <National Basic Medical Insurance, Maternity Insurance, and Work-related Injury Insurance Drug List> and the <Commercial Health Insurance Innovative Drug List> (2025)" (Medical Insurance Development [2025] No. 33). According to the notice, the company's exclusive products Wen Yang Jie Du granules, Yu Nu Jian granules, and the domestic first generic drug product Sumaputan Telmisartan Sodium Tablets have been included in the "National Basic Medical Insurance, Maternity Insurance, and Work-related Injury Insurance Drug List (2025)" for the first time through negotiations.